表观基因组
H3K4me3
表观遗传学
DNA甲基化
生物
主旨
表观遗传学
组蛋白
癌症研究
遗传学
基因
基因表达
间质细胞
发起人
作者
Takeshi Niinuma,HIROSHI KITAJIMA,Eiichiro Yamamoto,Reo Maruyama,Hironori Aoki,Taku Harada,Kazuya Ishiguro,Gota Sudo,Mutsumi Toyota,Ayano Yoshido,Masahiro Kai,Hiroshi Nakase,Tamotsu Sugai,Hiromu Suzuki
出处
期刊:Anticancer Research
[International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
日期:2021-06-01
卷期号:41 (6): 2817-2828
被引量:9
标识
DOI:10.21873/anticanres.15062
摘要
BACKGROUND/AIM: Epigenetic alterations play an important role in the pathogenesis of gastrointestinal stromal tumors (GISTs). To obtain further insight into the GIST epigenome, we analyzed genome-wide histone modification and DNA methylation in GIST cells. MATERIALS AND METHODS: To reverse epigenetic silencing, GIST-T1 cells were treated with a DNA methyltransferase inhibitor and a histone deacetylase inhibitor, and subsequently H3K4me3 levels, the DNA methylome, and the transcriptome were analyzed. RESULTS: Treatment with epigenetic inhibitors not only up-regulated genes with DNA methylation, but also genes related to interferon signaling. ChIP-seq analysis revealed that drug treatment up-regulated H3K4me3 levels in retrotransposons, including endogenous retroviruses (ERV). Finally, utilizing the omics data, we found that hypermethylation of MEG3 is a frequent event and an indicator of poorer prognosis in GIST patients. CONCLUSION: Epigenetic inhibitors may activate interferon signaling via viral mimicry in GIST cells. Moreover, epigenome data could be a useful resource to identify novel GIST-related genes.
科研通智能强力驱动
Strongly Powered by AbleSci AI